News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TSX Delisting of Inflazyme Pharmaceuticals Ltd.
November 20, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO, Nov. 20 /CNW/ - At the request of the Company, the common shares of Inflazyme Pharmaceuticals Ltd. (Symbol: IZP) will be delisted at the close on Wednesday, November 21, 2007.
Twitter
LinkedIn
Facebook
Email
Print
